mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

	Gene Summary
	Ligand Binding Site Mutation Information
	Protein Structure Related Information
	Gene Expression and Gene-Gene Network
	Phenotype Information
	Pharmacological Information
	Conservation Information for LBS

Gene summary for HIST1H2BB

Gene summary

Basic gene Info.	Gene symbol	HIST1H2BB
	Gene name	histone cluster 1, H2bb
	Synonyms	H2B.1\|H2B/f\|H2BFF
	Cytomap	UCSC genome browser: 6p21.3
	Type of gene	protein-coding
	RefGenes	NM_021062.2,
	Description	H2B histone family, member Fhistone 1, H2bbhistone H2B type 1-Bhistone H2B.1histone H2B.f
	Modification date	20141207
dbXrefs	MIM : 602803
	HGNC : HGNC
	Ensembl : ENSG00000276410
	HPRD : 07536
	Vega : OTTHUMG00000014421
Protein	UniProt: P33778 go to UniProt's Cross Reference DB Table
Expression	CleanEX: HS_HIST1H2BB
	BioGPS: 3018
Pathway	NCI Pathway Interaction Database: HIST1H2BB
	KEGG: HIST1H2BB
	REACTOME: HIST1H2BB
	Pathway Commons: HIST1H2BB
Context	iHOP: HIST1H2BB
	ligand binding site mutation search in PubMed: HIST1H2BB
	UCL Cancer Institute: HIST1H2BB
Assigned class in mutLBSgeneDB	C: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez

GO ID

GO Term

PubMed ID

Top

Ligand binding site mutations for HIST1H2BB

Cancer type specific mutLBS sorted by frequency

LBS	AAchange of nsSNV	Cancer type	# samples
S92	E94D	BRCA	1
E36	E36K	LUAD	1
S37	S37I	STAD	1
S57	S57T	UCEC	1

cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.

Top

Protein structure related information for HIST1H2BB

Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
(ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)

: nsSNV at non-LBS

: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.

LBS	AAchange of nsSNV	Relative stability change
S92	E94D	-1.2252818
S37	S37I	-0.96367863
E36	E36K	-0.92217044
S57	S57T	-0.5477315

(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for HIST1H2BB from PDB

Top

Differential gene expression and gene-gene network for HIST1H2BB

Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)

* Left PPI network was created from samples with mutations in the LBS of HIST1H2BB and the right PPI network was created from samples without mutations in the LBS of HIST1H2BB. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.

Top

Phenotype information for HIST1H2BB

Gene level disease information (DisGeNet)

Disease ID

Disease name

# PubMed

Association type

Mutation level pathogenic information (ClinVar annotation)

Allele ID

AA change

Clinical significance

Origin

Phenotype IDs

Top

Pharmacological information for HIST1H2BB

Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.